Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care
NCT04375358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2021-06-02
Summary
Acute renal failure is a common complication in patients admitted to intensive care. Due to the increasing incidence of acute renal failure, the use of Continuous Renal Replacement Therapy (CRRT) is on the rise in the intensive care unit. The use of CRRT exposes patients to some complications (bleeding, hemodynamic instability, antibiotic underdosing, malnutrition and infections), justifying the importance of optimizing the quality and reliability of this technique. Renal function is classically assessed by diuresis and creatinine. Creatinine clearance is an indirect measure of glomerular filtration rate. Measuring creatinine clearance is a simple, accessible and relatively inexpensive method. Traditionally, clreatinine clearance has required 24-hour urine collection. However, it has been shown that two-hour urine collection is also an accurate tool.
There is little information and few recommendations as to when to discontinue CRRT. A predictive index for the withdrawal of CRRT would reduce the duration of treatment, reduce complications and costs, and speed up patient rehabilitation.
Various parameters have been described as tools for deciding when to stop dialysis: diuresis before stopping CRRT, urine and blood creatinine, daily urinary urea excretion, and sodium and water balance. Among these factors, urine output and creatinine appear to be promising predictive factors. The measurement of creatinine clearance combines these two factors and can therefore be a good tool for predicting the return of adequate renal function. Retrospective work carried out by Fröhlich et al in 2012 suggested that creatinine clearance measured over 2 hours could be a good marker for successful withdrawal.
The hypothesis of the study is that creatinine clearance measured over 2 hours after stopping CRRT is be predictive of the success of the withdrawal from this type of therapy.
Conditions
- Dialysis Withdrawal
- Creatinine Clearance
Interventions
- BIOLOGICAL
-
Blood and urine samples
To measure the clearance of creatinine, urea, potassium, magnesium, sodium, chlorine...
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Dijon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2021-03-30
- Completion
- 2021-03-30
Countries
- France
Study Locations
More Related Trials
-
Investigating Different Anticoagulants for Renal Replacement Therapy
NCT02669589 ·Status: COMPLETED ·Phase: PHASE4
-
Discontinuing CRRT in Patients with Acute Kidney Injury
NCT04898595 ·Status: COMPLETED ·Phase: NA
-
Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy
NCT01269112 ·Status: COMPLETED ·Phase: PHASE4
-
Predictive Score for the Success of Discontinuation of Renal Replacement Therapy (RRT) in Intensive Care
NCT07317362 ·Status: COMPLETED
-
Effect of CRRT Duration on Solute Removal
NCT04458571 ·Status: COMPLETED
-
Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
NCT03314363 ·Status: COMPLETED ·Phase: NA
-
Detailed Assessment of Augmented Renal Clearance in a Large Mixed Intensive Care Unit Population
NCT03954275 ·Status: UNKNOWN
-
Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study
NCT04755491 ·Status: COMPLETED
-
Outcomes of Critically Ill Patients Undergoing RRT- a Registry Based Study.
NCT06897254 ·Status: COMPLETED
-
Impact of the Characteristics of Acute Renal Failure in Intensive Care on the Long-term Renal Prognosis: Prospective Multicenter Cohort Study
NCT05247502 ·Status: RECRUITING
-
Perfusion - Pressure - Creatinine Trial
NCT01408420 ·Status: COMPLETED ·Phase: NA
-
CRRTNet Registry- A Prospective Observational Registry
NCT02034448 ·Status: UNKNOWN
-
PREdiction of succeSSful weanING From Continuous Renal Replacement Theraphy: the Possible Role of Delta C-cistatin
NCT06714214 ·Status: RECRUITING
-
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT06646328 ·Status: TERMINATED ·Phase: PHASE4
-
Albumin To Enhance Recovery After Acute Kidney Injury
NCT04705896 ·Status: RECRUITING ·Phase: PHASE4
-
2012_PharmacoCRRT-study:Pharmacokinetics of Anti-infectives in Critically Ill Patients in Need of Continuous Renal Replacement Therapy (CRRT)
NCT01582360 ·Status: UNKNOWN
-
Renal Physiology During Continuous Renal Replacement Therapy
NCT04114747 ·Status: RECRUITING ·Phase: NA
-
Renal Replacement Anticoagulant Management
NCT03545750 ·Status: UNKNOWN
-
Timing of Renal Replacement Therapy in the Critically Ill Patients
NCT03629977 ·Status: RECRUITING
-
Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis
NCT00752245 ·Status: WITHDRAWN ·Phase: NA
-
Continuous Renal Replacement Therapy for Acute Kidney Injury by Cooling Blood
NCT04103307 ·Status: WITHDRAWN ·Phase: PHASE2
-
CRRT Timing in Sepsis-associated AKI in ICU
NCT03175328 ·Status: UNKNOWN ·Phase: NA
-
Citrate Versus Heparin in Continuous Renal Replacement Therapy :
NCT04865510 ·Status: COMPLETED ·Phase: NA
-
Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program
NCT02663960 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Outcome of Acute Kidney Disease
NCT03597854 ·Status: UNKNOWN